Herjan Coelingh Bennink
Founder at Pantarhei Bioscience BV
Herjan Coelingh Bennink active positions
Companies | Position | Start | End |
---|---|---|---|
Pantarhei Bioscience BV
Pantarhei Bioscience BV Pharmaceuticals: MajorHealth Technology Pantarhei Bioscience BV is a bio-pharmaceutical company located in Zeist, Netherlands, that develops new treatments for women's health and reproductive endocrine oncology. Pantarhei's objective is to discover and develop safe and effective new treatments for women's health and reproductive endocrine oncology using existing targets, hormones, biologicals, and drugs. The Dutch company has extensive experience in the clinical development and creation of new drugs. Pantarhei develops patent-protected treatments up to phase II efficacy and safety, and after generating favorable human proof-of-concept efficacy and safety data, projects are sold or licensed-out to a (pharmaceutical) partner for final development (phase III), regulatory approval, and commercialization. The private company was founded in 2000 by Herjan Coelingh Bennink, and Yvette Zimmerman has been the CEO since 2007. | Director/Board Member | 2000-12-27 | - |
Founder | 2000-12-27 | - | |
President | 2000-12-27 | - | |
Pantarhei Oncology BV | Chairman | 2013-12-31 | - |
Founder | 2013-12-31 | - | |
Oxytone Bioscience BV | Chairman | - | - |
Career history of Herjan Coelingh Bennink
Former positions of Herjan Coelingh Bennink
Companies | Position | Start | End |
---|---|---|---|
Université Libre de Bruxelles | Corporate Officer/Principal | 1996-12-31 | 2004-12-31 |
Organon BioSciences NV
Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Corporate Officer/Principal | 1999-12-31 | 1999-12-31 |
MITHRA PHARMACEUTICALS S.A. | Director/Board Member | - | - |
Delphi Bioscience BV
Delphi Bioscience BV Pharmaceuticals: MajorHealth Technology Delphi Bioscience BV develops health screening solutions for vaginal and cervical infections. It offers Delphi Screener, a self-sampling device which can be used by women or doctors, to collect reliable cervico-vaginal samples without the need for inserting a speculum during a pelvic exam. The company was founded in 2006 and is headquartered in Scherpenzeel, the Netherlands. | Chief Executive Officer | 2011-05-17 | - |
Chairman | 2011-05-17 | 2011-05-17 | |
President | 2011-05-17 | - |
Training of Herjan Coelingh Bennink
Erasmus University Rotterdam | Doctorate Degree |
University of Utrecht | Doctorate Degree |
Statistics
International
Netherlands | 8 |
Belgium | 3 |
Operational
Chairman | 3 |
President | 2 |
Doctorate Degree | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
MITHRA PHARMACEUTICALS S.A. | Health Technology |
Private companies | 5 |
---|---|
Delphi Bioscience BV
Delphi Bioscience BV Pharmaceuticals: MajorHealth Technology Delphi Bioscience BV develops health screening solutions for vaginal and cervical infections. It offers Delphi Screener, a self-sampling device which can be used by women or doctors, to collect reliable cervico-vaginal samples without the need for inserting a speculum during a pelvic exam. The company was founded in 2006 and is headquartered in Scherpenzeel, the Netherlands. | Health Technology |
Organon BioSciences NV
Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Health Technology |
Pantarhei Bioscience BV
Pantarhei Bioscience BV Pharmaceuticals: MajorHealth Technology Pantarhei Bioscience BV is a bio-pharmaceutical company located in Zeist, Netherlands, that develops new treatments for women's health and reproductive endocrine oncology. Pantarhei's objective is to discover and develop safe and effective new treatments for women's health and reproductive endocrine oncology using existing targets, hormones, biologicals, and drugs. The Dutch company has extensive experience in the clinical development and creation of new drugs. Pantarhei develops patent-protected treatments up to phase II efficacy and safety, and after generating favorable human proof-of-concept efficacy and safety data, projects are sold or licensed-out to a (pharmaceutical) partner for final development (phase III), regulatory approval, and commercialization. The private company was founded in 2000 by Herjan Coelingh Bennink, and Yvette Zimmerman has been the CEO since 2007. | Health Technology |
Pantarhei Oncology BV | |
Oxytone Bioscience BV |